Aflac (NYSE:AFL – Get Free Report) had its price objective raised by investment analysts at Morgan Stanley from $113.00 to $118.00 in a research note issued on Monday,Benzinga reports. Morgan Stanley’s price objective suggests a potential upside of 3.41% from the company’s current price. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $111.00. Get Aflac alerts:View Our Latest Analysis on AflacAflac Stock PerformanceShares of Aflac stock traded down $0.23 on Monday, reaching $114.11. Aflac Company Profile(Get Free Report)Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products.